KMT2A activates cell proliferation via HOXA9, and MEIS1 upregulation and is therefore a major player in leukemogenesis [20, 21, 22]: roughly every second acute leukemia is characterized by aberrantly increased HOXA9 expression [23, 24]. This evidence concerns the gene KMT2A and acute leukemia.